Japan March retail sales +1.7% y/y, seasonally-adjusted retail sales +1.3% m/m
StreetAccount Sector Preview - Japan Chemicals Jan-Mar Earnings
Asahi Kasei completes acquisition of Aicuris Anti-infective Cures (¥1559.0000, 0)
PeptiDream partner Asahi Kasei Therapeutics initiates phase 1 trial of AK1940 (¥1192.0000, 0)
Powered by FactSet Research Systems Inc.